Physician profile
Michael G Robson
NPI 1386627602
$1,814.34
in general payments reported to CMS, 2019-2025
22 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $429 · 2020: $222 · 2021: $140 · 2022: $429 · 2023: $172 · 2024: $132 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $594.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $491.83 | 2019-2025 | Collagenase Santyl, Grafix Pl, Oasis |
| Paratek Pharmaceuticals, INC. | $182.71 | 2019-2025 | Nuzyra |
| Organogenesis INC. | $166.60 | 2019-2025 | Apligraf |
| Melinta Therapeutics, LLC | $133.92 | 2019-2022 | |
| Next Science LLC | $129.26 | 2023 | Blastx, Xperience, Surgx |
| Integra Lifesciences Corporation | $89.25 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $80.38 | 2019-2025 | |
| Kerecis Limited | $74.53 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Abbvie INC. | $66.91 | 2022-2025 | |
| Musculoskeletal Transplant Foundation INC. | $61.22 | 2019-2021 | |
| Mimedx Group, INC. | $44.57 | 2024-2025 | |
| Solventum Corporation | $41.67 | 2024-2025 | Activ.A.C. |
| Kci USA, INC. | $40.77 | 2020-2023 | Promogran Prisma, Activ.A.C. |
| Tei Medical INC. | $37.61 | 2019 | |
| Bioventus LLC | $35.86 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.40 | 2019 | |
| Ovik Health, LLC | $26.34 | 2021 | |
| Osiris Therapeutics INC. | $20.31 | 2019 | |
| Hartmann USA, INC. | $19.80 | 2022 | |
| Hydrofera LLC | $18.45 | 2022 | |
| Convatec INC. | $14.78 | 2019 | |
| Allergan, INC. | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Robson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.